Mutations in the p53 tumour suppressor gene in thyroid tumours of children from areas contaminated by the Chernobyl accident

References

• BARNES, D. M., DUBLIN, E. A., FISHER, C. J., LEVISON, D. A. and MILLIs, R. R., 1993, Immunohistochemical detection of p53 protein in mammary carcinoma: an important new independent indicator of prognosis? Human Pathology, 24, 469–476.
   Google Scholar
• BAVERSTOCK, K., EGLOFF, p., PINCHERA, A., RUCHTI, C. and WILLIAMS, D., 1992, Thyroid cancer after Chernobyl. Nature, 359, 21–22.
   PubMed Web of Science ®Google Scholar
• DOCKHORN-DWORNICZAK, B., SCHRoDER, S., DANTCHEVA, R., TC:YrscH, M., STUCKER, A., BRöMMELKAMP, E., BANKFALVI, A., BOCKER, W. and SCHMID, K. W., 1993, The role of the p53 tumor suppressor gene in human thyroid cancer. Experimental Clinical Endocrinology, 101, 39–46.
   Google Scholar
• FACIN, J. A., MATSU°, K., KARMAKAR, A., CHEN, D. L., TANG, S. H. and KOEFFLER, H. P., 1993, High prevalence of muta-tions of the p53 gene in poorly differentiated human thyroid carcinomas. Journal of Clinical Investigations, 91, 179–184.
   Google Scholar
• GREENBLATT, M. S., BENNETT, W. P., HOLLSTEIN, M. and HARRIS, C. C., 1994, Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Research, 54, 4855–4878.
   PubMed Web of Science ®Google Scholar
• HARRIS, C. C. and HOLLSTEIN, M., 1993, Clinical implications of the p53 tumor-suppressor gene. New England Journal of Medicine, 28, 1318–1327.
   Google Scholar
• HEI, T. K., BEDFORDJ. and WALDREN, C. A., 1994, p53 mutation hotspot in radon-associated lung cancer. Lancet, 343, 1158–1159.
   Google Scholar
• IGGO, R., GATTER, K., BARTEK, J., LANE, D. and HARRIS, A. L., 1990, Increased expression of mutant forms of p53 oncogene in primary lung cancer. Lancet, 335, 675–679.
   PubMed Web of Science ®Google Scholar
• ITO, T., SEYAMA, T., MIZUNO, T., TSUYAMA, N., HAYASHI, T., HAYASHI, Y, DOHI, K., NAKAMURA, N. and AKIYAMA, M., 1992, Unique association of p53 mutations with undifferentiated but not with differentiated carcino-mas of the thyroid gland. Cancer Research, 52, 1369–1371.
   PubMed Web of Science ®Google Scholar
• ITO, T., SEYAMA, T., IwAmoTo, K. S., MIZUNO, T., TRONKO, N., KOMISSARENKO, I. V., CHERSTOVOY, E. D., SATOW, y, TAKEL-CHI, N., Dom, K. and AKLYAMA, M., 1994, Activated RET oncogene in thyroid cancers of children from areas contaminated by Chernobyl accident. Lancet, 344, 259.
   Google Scholar
• MCWHIRTER, W. R. and PETROESCHEVSKY, A. L., 1990, Childhood cancer incidence in Queensland, 1978-88. Inter-national Journal of Cancer, 45, 1002–1005.
   PubMed Web of Science ®Google Scholar
• PURDIE, C. A., O'GRADY, J., Pnos, J., WYLLIE, A. and BIRD, C., 1991, p53 expression in colorectal tumors. AmericanJournal of Pathology, 138, 807–813.
   Google Scholar
• RIESNER, D., STEGER, G., ZIMMAT, R., OWENS, R. A., WAGENHCDFER, M., HILLEN, W., VOLLBACH, S. and HENCO, K., 1989, Temperature-gradient gel electrophoresis of nucleic acids: analysis of conformational transitions, sequence variations, and protein-nucleic acid interactions. Electrophoresis, 10, 377–389.
   PubMed Web of Science ®Google Scholar
• SOUSSI, T., DE FROMENTEL, C. and MAY, P., 1990, Structural aspects of the p53 protein in relation to gene evolution. Oncogene, 5, 945–952.
   PubMed Web of Science ®Google Scholar
• TAYLOR, J. A., WATSON, M. A., DEVEREUX, T. R., MICHELS, R. Y, SACCOMANNO, G. and ANDERSON, M., 1994, p53 mutation hotspot in radon-associated lung cancer. Lancet, 343, 86–87.
   PubMed Web of Science ®Google Scholar
• THOR, A. D., MOORE, D. H., EDGERTON, S. M., KAWASAKI, E. S., REIHSAUS, E. and LYNCH, H. T., 1992, Accumulation of p53 tumor supressor gene protein: an independent marker of prognosis in breast cancer. Journal of the National Cancer Institute, 84, 845–855.
   PubMed Web of Science ®Google Scholar
• VAN DEN BERG, . M., TIGGES, A. J., SCHIPPER, M. E., DEN HARTO-JAGER, F. C., KROES, W. G. and WALBOOMERSJ. M., 1989, expression of the nuclear oncogene p53 in colon tumours. Journal of Pathology, 157, 193–199.
   Google Scholar
• VAHAKANGAS, K. H., SAMET, J. M., METCALF, R. A., WELSH, J. A., BENNETT, W. P., LANE, D. P. and HARRIS, C. C., 1992, Mutations of p53 and ras genes in radon-associated lung cancer from uranium miners. Lancet, 339, 576–579.
   PubMed Web of Science ®Google Scholar
• VENITT, S. and Bicos, p. J., 1994, Radon, mycotoxins, p53, and uranium mining. Lancet, 343, 795.
   PubMed Web of Science ®Google Scholar
• WILLIAMS, D., PINCHERA, A., KARAOGLOU, A. and CHADWICK, K. H., 1993, Thyroid cancer in children living near Cher-nobyl. Commission of the European Communities. Radiation Protection Research and Training Programme, 1–108.
   Google Scholar
• WRIGHT, P. A., LEMOINE, N. R., GORETZKI, P. E., WYLLIE, F. S., BOND, J. and HUGHES, C., 1991, Mutation of the p53 in a differentiated human thyroid carcinoma. Oncogene, 6, 1693–1697.
   PubMed Web of Science ®Google Scholar
• WRIGHT, P. A., WILLIAMS, E. D., LEMOINE, N. R. and WYNFORD-THOMAS, D., 1991, Radiation associated and 'sponta-neous' human thyroid carcinoma show a different pattern of ras oncogene mutation. Oncogene, 6, 471–473.
   Google Scholar
• WU, X., BAYLE, J. H., OLSON, D. and LEVINE, A. J., 1993, The p53-mdm-2 autoregulatory feedback loop. Genes Development, 7, 1126–1132.
   PubMed Web of Science ®Google Scholar
• YOUNG, J. L., RIES, L. G., SILVERBERG, E., HoRm, J. W. and MILLER, R. W., 1986, Cancer incidence, survival, and mortality for children younger than age 15 years. Cancer, 58, 598–602.
   PubMedGoogle Scholar
• ZOU, M., SHI, Y and FARAD, N. R., 1993, p53 mutations in all stages of thyroid carcinomas. Journal of Clinical Endo-crinology and Metabolism, 77, 1054–1058.
   Google Scholar